1 / 5

Diagnostic Biomarker Market Trends, Size, Competitive Analysis and Forecast 2018

Diagnosis is defined as an assessment to identify the root cause of an illness and the effects caused by the diseases or illness. It enables to determine the symptoms caused by the illness, and solution to overcome the disease.

Meenoo
Download Presentation

Diagnostic Biomarker Market Trends, Size, Competitive Analysis and Forecast 2018

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Orion Market Research Diagnostic Biomarker Market, Size, Share, Analysis Report & Forecast to 2023 To Market: https://www.omrglobal.com/request-sample/diagnostic-biomarker-market Request a Sample of our Report on Diagnostic Biomarker Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +91 780-304-0404

  2. The global diagnostic biomarker market is significantly increased during the forecast period.The biomarker is the technology that is used to detectthe incidence and outcome of the disease. A biomarker may be a molecular secreted that is obtained from the blood, or tissue, blood fluids, and tumor. The biomarker technology has become an essential part of diagnosis cancer and enables patients with the benefit-risk balance to receive certain treatments. Cancer is referred toas an abnormal growth of the cells. Cancer biomarker is a process or substance that indicates the presence of cancer in the body. Genetic, epigenetic, glycemic, proteomic, and imaging biomarkers are used for cancer diagnosis, prognosis, and epidemiology. (Get 15% Discount on Buying this Report) A full Report of Diagnostic Biomarker Market is Available at: https://www.omrglobal.com/industry- reports/diagnostic-biomarker-market The cancer biomarkers used as risk indicators for various types of cancer such as lung cancer, breast cancer, and prostate cancer among others. Key cancer biomarkers include SCC, CEA, NSECyfra 21, PSA (prostate cancer), TPA (Lung cancer), CA15-3, EGF R, and Cytokeratin 4 (breast cancer). There are various key factors that are attributing towards the growth of the global diagnostic biomarker market such as the development are increasing using of biomarkers in the field of diagnostics and drug discovery, improvement in R&D funding from government and rising prevalence of cancer. For the development of biomarkers, the high capital investment is required and the high cost is required for cancer diagnosis is the factor affecting the growth of the global diagnostic biomarker market. The biomarkers are commonly used for breast cancer that is used to reduce the risk of cancer such as hormone therapy drugs and enable them to treat breast cancer. Moreover, tamoxifen and raloxifene have been used for the prevention of breast cancer. The hormone receptor (HR) positive breast cancers are those that contain estrogen receptor (ER) and progesterone receptor (PR) due to this cancer grow in response to these hormones and can be treated with hormone therapies. The human epidermal growth factor receptor 2 that is (HER2) has been endorsed to be a prognostic factor and predictor of response to HER2 targeting therapy. The biomarker is used to quantify the residual risk of patients and to indicate the potential value of additional treatment strategies. Furthermore, the inhibitors also play a prominent role in breast cancer such as aromatase inhibitors that consist of exemestane and anastrozole. Due to changing levels of ovarian hormones, it makes less estrogen such inhibitors have been used flourishing the growth of the global diagnostic biomarker market. To Request a Sample of our Market: https://www.omrglobal.com/request-sample/diagnostic-biomarker-market Report on Diagnostic Biomarker Global Diagnostic Biomarker Market- Segmentation By Application •Oncology •Cardiology •Neurology •Other By Diagnostic Technique •Elisa •Colorimetric Assay

  3. •Liquid Chromatography-Mass Spectrometry •Particle-Enhanced Turbidimetric Immunoassay •Other By End-Users •Hospitals & Diagnostic Labs •Research Centers Regional Analysis North America •United States •Canada Europe •UK •Germany •Spain •France •Italy •Rest of Europe Asia-Pacific •India •China •Japan •Rest oF APAC Rest of The World • • • Latin America Middle East and Africa COMPANY PROFILES ABASTAR MDX INC. ABBOTT LABORATORIES INC. ACUMEN PHARMACEUTICALS INC. ADLYFE INC. AGENDIA BV ASTELLAS PHARMA INC. ASTUTE MEDICAL, INC. AVACTA GROUP PLC BANYAN BIOMARKERS BAYER AG BECKMAN COULTER INC. BECTON, DICKSON & CO. BG MEDICINE INC. BIOMARKER TECHNOLOGIES, INC.

  4. BIOMERIEUX S.A. BIOPORTO A/S BIO-RAD LABORATORIES CISBIO BIOASSAYS COVANCE INC. CRITICAL DIAGNOSTICS INC. DIAGENIC ASA ENZO LIFE SCIENCES, INC. EUROIMMUN AG EVOTEC A.G. EXACT SCIENCE CORPORATION F. HOFFMANN-LA ROCHE LTD. GENENEWS LTD. ILLUMINA, INC. INOVA DIAGNOSTIC INC. LUMINEX CORPORATION MERCK & CO. INC. METABOLON INC. MYRIAD GENETICS INC. NANOSTRING TECHNOLOGIES INC. NOVARTIS AG PACIFIC BIOMARKERS INC. PLATO BIO PHARMA INC. PLIANT THERAPEUTICS, INC. QIAGEN N.V. QUEST DIAGNOSTICS INC. R & D SYSTEMS RANDOX LABORATORIES LTD. RESPONSE BIOMEDICAL CORPORATION SIEMENS AG SIGNOSIS INC. Reasons to Buying From us – 1. We cover more than 15 major industries, further segmented into more than 90 sectors. 2. More than 120 countries are for analysis. 3. Over 100+ paid data sources mined for investigation. 4. Our expert research analysts answer all your questions before and after purchasing your report. For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report- customization/diagnostic-biomarker-market About Orion Market Research Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research- based services.

  5. For More Information, Visit Orion Market Research Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +91 7803040404

More Related